You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022406030
Dec 2022110015
Jan 2023130012
Feb 202396012
Mar 202378014
Apr 2023106015
May 2023106013
Jun 20236209
Jul 202344016
Aug 20234208
Sep 20231607
Oct 202313008
Nov 20237008
Dec 20239009
Jan 202412009
Feb 202456011
Mar 202488012
Apr 20246205
May 20245506
Jun 20245306
Jul 202442010
Aug 20243205
Total19940240